Dr Shafeek undertook his Haemato-oncology training at the West Midlands Regional rotation from 1994 and was then Consultant Haematologist at Worcestershire Royal Hospital from July 2002.
Dr Shafeek has been Clinical Director for Haematology & Oncology at Worcestershire Acute NHS Trust since 2009. As the senior Haematologist this puts him in charge of Clinical Haematology for the Worcestershire County and places him lead in the Haematology consultant team.
Dr Shafeek is Senior Lecturer in Haematology at the University of Birmingham and has been since 2005 and this links him closely to cancer studies and research activities into Myeloma, Lymphoma, Leukaemia and Myeloproliferative disorder.
He has been a member of Worcestershire Oncology Project team since 2010 and was actively involved in the restructuring of the cancer network in Worcestershire.
Dr Shafeek is the current lead for countywide anticoagulation and set up the secondary care new anticoagulation service, which included Warfarin dosing, and DVT clinics. He is also the deputy chair for the trust wide thrombosis committee and is actively involved in the Thromboprophylaxis program and risk assessment for the acute trust and community hospitals for Worcestershire PCT.
Dr Shafeek’s special interest is in Myeloma and Lymphoma, he is the principal investigator for all the National Clinical Trials in Worcestershire Acute NHS Trust. This includes AML17, AML16, Myeloma XI, Myeloma IX, RATHL, Pacifico and PASS studies.